Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. 1975

G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant

Sera from patients with Kaposi's sarcoma (KS) were examined for antibody titres to cytomegalovirus (CMV), Epstein-Barr virus (EBV) and herpes simplex virus (HSV) types 1 and 2 by four techniques: indirect haemagglutination (IHA), complement fixation (CF), virus neutralization (NT) and indirect immunofluorescence (IF). The patients were classified, according to the stage of disease, as progressive and regressive. Control sera were obtained from healthy adults, matched for age, sex, race, socioeconomic status and geographic location, as well as from patients with melanoma, some of whom were receiving chemotherapy similar to that given to the KS patients. All KS sera contained CMV-neutralizing antibodies. Seventy-five percent of the European KS patients, mainly regressors, showed elevated anti-CMV titres by IHA with a significant increase in the geometric mean over the corresponding healthy adult group and the melanoma group. An overrepresentation of high anti-CMV titres, although less marked, was found by CF. There was no significant association with antibodies to EBV, HSV-1 and HSV-2 related antigens. By contrast, the African KS patients, mainly progressors, did not show a serologic association with CMV or with EBV and HSV-1 and 2. The implication of these results is discussed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D003168 Complement Fixation Tests Serologic tests based on inactivation of complement by the antigen-antibody complex (stage 1). Binding of free complement can be visualized by addition of a second antigen-antibody system such as red cells and appropriate red cell antibody (hemolysin) requiring complement for its completion (stage 2). Failure of the red cells to lyse indicates that a specific antigen-antibody reaction has taken place in stage 1. If red cells lyse, free complement is present indicating no antigen-antibody reaction occurred in stage 1. Complement Absorption Test, Conglutinating,Conglutination Reaction,Conglutinating Complement Absorption Test,Complement Fixation Test,Conglutination Reactions,Fixation Test, Complement,Fixation Tests, Complement,Reaction, Conglutination,Reactions, Conglutination,Test, Complement Fixation,Tests, Complement Fixation
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006384 Hemagglutination The aggregation of ERYTHROCYTES by AGGLUTININS, including antibodies, lectins, and viral proteins (HEMAGGLUTINATION, VIRAL). Hemagglutinations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
July 1987, The Journal of infectious diseases,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
March 1989, Oral surgery, oral medicine, and oral pathology,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
September 1983, Bollettino dell'Istituto sieroterapico milanese,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
August 1982, The Journal of investigative dermatology,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
August 2011, Journal of gastroenterology and hepatology,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
March 1988, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
January 1983, Antibiotics and chemotherapy,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
January 1983, AIDS research,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
July 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
G Giraldo, and E Beth, and F M Kourilsky, and W Henle, and G Henle, and V Miké, and J M Huraux, and H K Andersen, and M R Gharbi, and S K Kyalwazi, and A Puissant
January 2001, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!